Mechanisms of Antifungal Drug Resistance.

Abstract

Antifungal therapy is a central component of patient management for acute and chronic mycoses. Yet, treatment choices are restricted because of the sparse number of antifungal drug classes. Clinical management of fungal diseases is further compromised by the emergence of antifungal drug resistance, which eliminates available drug classes as treatment options. Once considered a rare occurrence, antifungal drug resistance is on the rise in many high-risk medical centers. Most concerning is the evolution of multidrug- resistant organisms refractory to several different classes of antifungal agents, especially among common Candida species. The mechanisms responsible are mostly shared by both resistant strains displaying inherently reduced susceptibility and those acquiring resistance during therapy. The molecular mechanisms include altered drug affinity and target abundance, reduced intracellular drug levels caused by efflux pumps, and formation of biofilms. New insights into genetic factors regulating these mechanisms, as well as cellular factors important for stress adaptation, provide a foundation to better understand the emergence of antifungal drug resistance.

• Authors: Leah E Cowen, Dominique Sanglard, Susan J Howard, P David Rogers, David S Perlin
• Journal: Cold Spring Harbor perspectives in medicine (Cold Spring Harb Perspect Med) Vol. 5 Issue 7 Pg. a019752 (Nov 10 2014) ISSN: 2157-1422 [Electronic] United States
• PMID: 25384768 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2015 Cold Spring Harbor Laboratory Press; all rights reserved.

Chemical References

• Antifungal Agents

Topics

• Antifungal Agents (classification, therapeutic use)
• Biofilms (drug effects)
• Drug Resistance, Fungal (genetics)
• Humans
• Mycoses (microbiology)
• RNA Stability